Virax Biolabs Group Ltd. (VRAX)
1.99
-0.12
(-5.69%)
USD |
NASDAQ |
Oct 08, 10:19
Virax Biolabs Group Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Interpace Biosciences, Inc. | 1.430 |
| Akso Health Group | 0.1865 |
| AstraZeneca PLC | 10.35 |
| GSK Plc | 3.986 |
| PD-Rx Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 61.76 |
| PEG Ratio | -0.0003 |
| Price | 1.99 |
| Earnings Yield | -849.8% |
| Market Cap | 1.153M |
| PEGY Ratio | -0.0003 |